Journal Information
Vol. 41. Issue 11.
Pages 641 (November 2005)
Vol. 41. Issue 11.
Pages 641 (November 2005)
Cartas al director
DOI: 10.1157/13081255
Full text access
Corticoides en las exacerbaciones de la EPOC: sí, pero menos
Visits
7185
H. Verea-Hernández
Servicio de Neumología. Hospital Juan Canalejo. La Coruña. España
Related content
Arch Bronconeumol. 2005;41:64110.1157/13081256
M. Carrera, E. Sala, B.G. Cosío, A.G.N. Agustí
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Carrera, E. Sala, B.G. Cosío, A.G. Agustí.
Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revision basada en la evidencia.
Arch Bronconeumol, 41 (2005), pp. 220-229
[2.]
L. Davies, R.M. Angus, P.M.A. Calverley.
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised trial.
Lancet, 354 (1999), pp. 456-460
[3.]
S.D. Aaron, K.L. Vandemheen, P. Hebert, R. Dales, I.G. Stiell, J. Ahuja, et al.
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
N Engl J Med, 348 (2003), pp. 2618-2625
[4.]
L.J. Walsh, C.A. Wong, J. Oborne, S. Cooper, M. Pringue, R. Hubbard, et al.
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
Thorax, 56 (2001), pp. 279-284
[5.]
C.E. Bolton, A.A. Ionescu, K.M. Shiels, R.J. Pettit, P.H. Edwards, M.D. Stone, et al.
Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 170 (2004), pp. 1286-1293
[6.]
F. De Vries, T.P. Van Staa, M.S. Bracke, C. Cooper, H.G. Leufkens, J.W. Lammers.
Severity of obstructive airway disease and risk of osteoporotic fractures.
Eur Respir J, 25 (2005), pp. 879-884
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica